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Eur J Vasc Endovasc Surg (2009) 37, 120e122CORRESPONDENCEEndovascular Repair of Aortic Transection can be
a Durable Treatment OptionWe enjoyed reading the paper by Mohan et al.1
Our experience in the endovascularmanagement of aortic
transection began in 1997. This patient was an 18-year old
male who on initial presentation underwent operative
management of both splenic and liver injuries, with the
diagnosis of aortic transection not made until 6 weeks after
the event. He subsequently underwent successful deploy-
ment of a Vanguard device (Boston Scientific, Natick, MA) via
an infrarenal conduit and has remained well during both
imaging and clinical follow up.
Although thisearly generationdevicewasnot thought tobe
durable it has performed well in the thoracic aorta for 11
years. Thismaybedue to the fact that this transectionwasnot
circumferential. It is possible that partial transections have
the ability heal and therefore the device is not subjected to
the same forces aswould be seen in a degenerative aneurysm.
Endovascular repair is so successful that it has become the
treatment of choice for aortic transection. The problem of
stent graft collapse will decrease with increasing experi-
ence, smaller stents and more compliant devices.
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a Durable Treatment OptionWe thank Messrs Clough and Taylor for their interest in our
paper.1 The case presented, highlights many of the difficul-
ties and challenges faced in this critically injured group of
patients, and it is without doubt that stent grafts should now
be the treatment of choice for thoracic aortic transections.
Questions of graft durability are still of concern in this young
patient cohort, and only time will provide the answers.
The pathology of thoracic aortic injury has been well
documented.2 While some aortic tears may heal over, they
are still at risk of chronic pseudoaneurysm formation, and
late rupture.3 The mechanical forces on the stent graft in
this condition may well be very different to that seen in
patients with established thoracic aneurysms, and this may
explain the longevity of the device used in their patient.
Despite the difficulties encountered with the early
generation commercially available endovascular devices in
aneurysmal disease, the Vanguard Device (Boston Scientific,
Natick, MA) has served this patient well.
We agree that continued evolution of the technique
will further decrease both patient and graft related
complications and provide further answers regarding graft
durability.
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